The pharmaceutical industry In Mexico it could multiply its growth between three and four times if the country promotes comprehensive regulatory modernization, he stated. Javier Dávilageneral director of Planning and Evaluation of the Ministry of Economy.
In his participation the forum “Medical Innovation: Transforming the lives of patients”, organized by Bayer and SuMédicosaid that the regulations must include the Federal Commission for the Protection against Health Risks (Cofepris)to the Mexican Institute of Industrial Property (WAR) and the entire legal framework related to the medical innovation.
You may also be interested in: Economy will increase investment in the agro-industrial development of Michoacán
Dávila Torres asserted that Mexico is “at a decisive point,” with talent, government interest and one strong industryalthough he acknowledged that delays have slowed investments and the arrival of new therapies. He acknowledged that sometimes regulatory slowness has caused clinical trials to migrate to South America.
Among the priorities, the digitalization of processes, parallel approvals with the European Medicines Agency (EMA, for its acronym in English) and by the Food and Drug Administration (FDA, for its acronym in English), the review of the legal framework and the modernization of the IMPI, essential to protect industrial property.
For its part, Daniel Londero, general director of Bayer Mexico, He highlighted that the company is developing more than 30 clinical studies in the country and evaluating another 40, focusing on specialties such as cardiology, urology, mental health and central nervous system.
Londero highlighted that Bayer works in advanced therapies with potential not only improve quality of lifebut to cure diseases that today seem impossible to treat.
10 and 12 million Mexicans live with chronic kidney disease
In the panel about chronic kidney diseaseDr. Ricardo Mendiola Fernández, of the Mexican Council of Nephrologywarned that between 10 and 12 million Mexicans live with this condition, but only 60,000 receive dialysis.
Mexico has barely mil 500 nephrologiststhat is, between 9 and 10 per million inhabitants, when the ideal is 20. The specialist urged to strengthen the timely detection from the first level of care to avoid serious complications.
During the table dedicated to hemophiliaspecialists of the Mexican Hemophilia Federation They highlighted the therapeutic advances that have transformed the lives of patients. They remembered that before prophylaxis, treatments consisted of “immobilization and ice”which led to permanent muscular and skeletal consequences.
You may also be interested in: Industrial leaders call to reactivate their economy and prioritize national consumption
In his speech, Carlos Flores ZarzaCCoordinator of Administrative Services of the Mexican Social Security Institute (IMSS), He stated that innovation in health goes beyond devices or technology: “It is breaking inertia and questioning what has always been done.”
He highlighted the implementation of the Digital Health Cardwhich allows more than 54 million people to consult their clinical information from the last 36 months, optimizing processes and strengthening the continuity of medical care.